538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)
- Resource Type
- Source
- Annals of Oncology. 32:S602-S603
- Subject
Chemotherapy Oncology medicine.drug_class business.industry medicine.medical_treatment Pancreatic cancer medicine Cancer research non-small cell lung cancer (NSCLC) Hematology medicine.disease Monoclonal antibody business - Language
- ISSN
- 0923-7534